Biocon News

How brewmaster Kiran Mazumdar-Shaw broke the glass ceiling with Biocon

The book has beautifully intertwined Shaw's life with the birth and evolution of Biocon. It has pictures of Shaw from childhood and also that of Biocon.

Biocon set to seek USFDA approval for biosimilars

Biosimilars are copies of biological drugs with same safety and efficacy as original products. The addressable market for Biocon in these countries is more than $30 billion.


Biocon Q2 Net flat at Rs 102 crore

Biotechnology major Biocon today reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter...

Biocon Q1 net profit up 9 pct to Rs 103 crore

Biocon's total revenue also rose to Rs 742 crore for the first quarter.

Novartis files patent suit against Biocon over diabetes drug

Novartis replaced the top managers at its Japanese unit after a third-party probe found employees had acted questionably in clinical trials on a leukaemia treatment.

Announcements galore,but no action

Govt has aggressively wooed firms to invest in state,but fate of proposals remains unknown


Biocon’s breast cancer drug to hit markets next month

The company said the drug, which would be manufactured at its biologics facility in Bangalore, will be sold to the patients at a discount.

Biocon inks pact with US-based Quark

The company,however,did not disclose financial details.

Biotech aiming to be $100 bn sector by 2025: Biocon chief Kiran Mazumdar-Shaw

Taking this road map is about delivering security including food security,health security,she said.

Biocon sets up centre of excellence,says biotech sector aims $100 bn revenue

Biotechnology major Biocon announced setting up of a centre of excellence for advanced learning